---
schema_version: "secwatch.filing_event.v1"
accession: "0001550695-24-000040"
form_type: "8-K"
ticker: null
cik: "0001550695"
company_name: "Performant Healthcare Inc"
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T18:06:59.256959+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Performant Q1 healthcare rev up 13% to $25.8M; net loss narrows to $4.0M; reaffirms FY24 guidance

## Summary
- Healthcare revenue $25.8M (+13% YoY); total revenue $27.3M (+6% YoY).
- Net loss of $4.0M ($0.05/sh) vs $4.2M ($0.06/sh) prior year; adjusted net loss $3.0M.
- Adj. EBITDA improved to $(1.2)M from $(1.7)M prior year.
- Reaffirmed FY2024 guidance: healthcare rev $117-122M, total rev $124-129M, adj EBITDA $4-5M.
- Acquired AI technology from RecordsOne in April; 10 commercial programs implemented in Q1.

## SEC filing metadata
- accession: 0001550695-24-000040
- form_type: 8-K
- cik: 0001550695
- company_name: Performant Healthcare Inc
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1550695/000155069524000040/0001550695-24-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1550695/000155069524000040/pfmt-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001550695-24-000040
- JSON: https://secwatch.observer/filing/0001550695-24-000040.json
- Plain text: https://secwatch.observer/filing/0001550695-24-000040.txt

## Key facts
- Earnings Releases
  Performant Healthcare Inc reported first quarter ended March 31, 2024 results: revenue $27.3 million, net income $(0.05) per diluted share. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: $27.3 million
  - Net income: $(0.05) per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Quarter Financial Highlights • Healthcare revenues of $25.8 million, compared to $22.9 million in the prior year period, an increase of approximately 13%. • Total revenues of $27.3 million, compared to total revenues of $25.7 million in the prior year period. • Net loss of $4.0 million, or $(0.05) per diluted share, compared to net loss of $4.2 million, or $(0.06)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1550695/000155069524000040/0001550695-24-000040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.